Skip to main content
Equibles
NUS logo

NUS · Nu Skin Enterprises, Inc. · Metrics

Track NUS — free

Use NUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.85 -0.03 (-0.61%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$236.08M
Shares
48.68M

NUS metrics

91 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.85
Market cap
$236.08M

Price action

20 metrics
Price change (1W)
+0.2%
Price change (30D)
+1.0%
Price change (3M)
-11.3%
Price change (6M)
-32.4%
Price change (YTD)
-49.6%
Price change (1Y)
-58.5%
Trailing year
Price change (5Y)
-89.8%
52-week high
$12.84
52-week low
$4.57
Change from 52-week high
-62.2%
Change from 52-week low
+6.1%
Annualized volatility
46.5%
Annualized volatility (3M)
43.3%
Beta
0.8
RSI (14D)
49.1
Price vs SMA 50
-3.1%
Price vs SMA 200
-33.8%
Avg volume (3M)
664,533
Relative volume
0.6
Average dollar volume
$3.35M

Company

3 metrics
Sector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
48.68M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.2×
reciprocal yield 532.3%
EV / EBITDA
6.5×
reciprocal yield 15.3%
EV / EBIT
—
P / sales
0.2×
reciprocal yield 582.5%
P / book
0.4
reciprocal yield 229.9%
FCF yield
4.6%
TTM · current market cap
Buyback yield
8.5%
P / FCF
21.9
reciprocal yield 4.6%
P / operating cash flow
4.6
reciprocal yield 21.5%
Earnings yield
-91.7%

Historical valuation

8 metrics
P / E historical average (3Y)
19.0×
reciprocal yield 5.3%
P / E historical average (5Y)
18.2×
reciprocal yield 5.5%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 303.0%
EV / revenue historical average (5Y)
0.6×
reciprocal yield 180.7%
EV / EBIT historical average (3Y)
15.7×
reciprocal yield 6.4%
EV / EBIT historical average (5Y)
14.9×
reciprocal yield 6.7%
EV / EBITDA historical average (3Y)
6.9×
reciprocal yield 14.5%
EV / EBITDA historical average (5Y)
8.4×
reciprocal yield 11.9%

Dividends & buybacks

7 metrics
Dividend yield
4.9%
Trailing 12 months
Payout ratio
—
Shareholder yield
13.4%
Dividend / share (TTM)
$0.24
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-28

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
69.2%
Operating margin
-0.8%
Trailing 12 months
Net margin
-15.7%
Gross profit (TTM)
$951.49M
Operating profit (TTM)
−$10.41M
Net income (TTM)
−$216.39M
Trailing 12 months
Diluted EPS (TTM)
$-4.49
FCF margin
0.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.56

Growth

11 metrics
Revenue growth YoY
-17.1%
Year over year
Net income growth YoY
-1,282.8%
Revenue (TTM)
$1.38B
Trailing 12 months
EPS growth YoY
-1,295.3%
Shares change YoY
-1.8%
Year over year · fewer shares
Revenue CAGR (3Y)
-12.6%
Revenue CAGR (5Y)
-10.5%
EPS CAGR (3Y)
+15.4%
EPS CAGR (5Y)
-2.6%
FCF CAGR (3Y)
-2.1%
FCF CAGR (5Y)
-32.0%

Quality

14 metrics
Return on equity
-39.9%
Return on assets
-19.3%
Debt / equity
0.4
Current ratio
2.0
EBITDA (TTM)
$39.60M
Free cash flow (TTM)
$10.78M
Quick ratio
1.2
Interest coverage
-0.7
Net debt / EBITDA
0.6
Return on invested capital
—
Trailing 12 months
Net cash
−$22.28M
Latest balance sheet
Cash & equivalents
$189.64M
Total assets
$1.12B
Total debt
$213.66M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$50.81M
Capital expenditures (TTM)
$40.03M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$13.79M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
161
13F filer change QoQ
-18
Institutional ownership
74.5%

Short interest

3 metrics
Short interest
9.3%
Latest settlement · 9.4 days to cover
Days to cover
9.4d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1021561 CUSIP 67018T105 13F (30d) 54 filings 54 filers Visit website Investor relations